Low- and middle-income countries will be able to purchase an effective preventative at a reduced price. The arrangements may help stem the epidemic 40 years after it began.
Category: Acquired Immune Deficiency Syndrome
Trump Budget Office Is Withholding H.I.V. Funds That Congress Appropriated
Lawmakers allocated $6 billion this fiscal year for PEPFAR, the H.I.V. prevention and treatment program, but the administration has indicated it will release less than half of that.
South African AIDS Activist Pushes for H.I.V. Treatment Access After U.S.-Aid Cuts
Zackie Achmat, once at the center of South Africa’s push for lifesaving H.I.V. treatment, has come out of retirement as U.S. funding cuts and his own government’s inertia revive old fears.
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
Regulators Approve Lenacapavir for H.I.V. Prevention
The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have paid for it in low-income countries.
South Africa Built a Medical Research Powerhouse. Trump Cuts Have Demolished It.
The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug companies, too.
Trump Budget Eliminates Funding for Crucial Global Vaccination Programs
The spending proposal terminates support of health programs that, according to the proposal, “do not make Americans safer.”
